Epclusa (sofosbuvir/velpatasvir) by Gilead Sciences
January 2016
Epclusa (sofosbuvir/velpatasvir) by Gilead Sciences Epclusa (sofosbuvir/velpatasvir) by Gilead Sciences Epclusa (sofosbuvir/velpatasvir) by Gilead Sciences New oral fixed-dose combination tablet for chronic hepatitis C....
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive